In the last two decades, calprotectin has been studied by several research groups, and the significant association between serum calprotectin and conventionally measured acute-phase reactants (CRP, ESR) [30, 31] as well as clinical variables of disease activity in patients with RA has been shown [5, 12]. This evidence concerns the gene CRP and rheumatoid arthritis.